HC Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$181K Buy
333
+30
+10% +$16.5K 0.12% 80
2022
Q1
$179K Hold
303
0.11% 82
2021
Q4
$202K Hold
303
0.11% 83
2021
Q3
$173K Sell
303
-88
-23% -$48.3K 0.1% 80
2021
Q2
$197K Hold
391
0.11% 81
2021
Q1
$178K Hold
391
0.11% 80
2020
Q4
$182K Hold
391
0.12% 82
2020
Q3
$173K Sell
391
-47
-11% -$19.4K 0.12% 74
2020
Q2
$159K Sell
438
-60
-12% -$20.1K 0.12% 70
2020
Q1
$141K Buy
+498
New +$157K 0.13% 72

Other funds holding TMO

HC Financial Advisors's TMO Position: Q2 2022 in Review

HC Financial Advisors increased its Thermo Fisher Scientific (TMO) stake by 9.9% in Q2 2022, buying an estimated $16.5K and bringing the position to 333 shares worth $181K. The position accounts for 0.12% of the portfolio, ranked #80.

HC Financial Advisors first reported a position in TMO in Q1 2020 and has held it in 10 quarters since. The position peaked at $202K in Q4 2021. 2,282 funds tracked by Wall St. Rank hold TMO as of Q2 2022.

  • HC Financial Advisors held 333 shares of Thermo Fisher Scientific worth $181K as of Q2 2022.
  • HC Financial Advisors bought 30 Thermo Fisher Scientific shares in Q2 2022, an estimated $16.5K.
  • Thermo Fisher Scientific made up 0.12% of HC Financial Advisors's portfolio in Q2 2022, its #80 holding.
  • HC Financial Advisors first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 10 quarters since.
  • HC Financial Advisors's Thermo Fisher Scientific position peaked at $202K in Q4 2021.
  • 2,282 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2022.

Based on HC Financial Advisors's 13F filing for Q2 2022, filed 25 Jul 2022.